MolMed’s strategy for growth is based on four key points:
Focus on oncology indications needing new options
Efficient clinical and pharmaceutical development, independently or with partners
In-house GMP manufacturing of cell and gene therapy products
Diversified pipeline to create value for shareholders
;)